Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RITUXIMAB-PVVR Cause Bone density abnormal? 10 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Bone density abnormal have been filed in association with RITUXIMAB-PVVR. This represents 0.2% of all adverse event reports for RITUXIMAB-PVVR.

10
Reports of Bone density abnormal with RITUXIMAB-PVVR
0.2%
of all RITUXIMAB-PVVR reports
0
Deaths
2
Hospitalizations

How Dangerous Is Bone density abnormal From RITUXIMAB-PVVR?

Of the 10 reports, 2 (20.0%) required hospitalization.

Is Bone density abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RITUXIMAB-PVVR. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does RITUXIMAB-PVVR Cause?

Off label use (2,079) Intentional product use issue (627) Condition aggravated (514) Death (338) Covid-19 (322) Fatigue (318) Dyspnoea (314) Inappropriate schedule of product administration (311) Headache (291) Pruritus (288)

What Other Drugs Cause Bone density abnormal?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,039) DENOSUMAB (643) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (580) ROMOSOZUMAB-AQQG (454) TENOFOVIR DISOPROXIL (310) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (276) EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (199) ADALIMUMAB (174) METHOTREXATE (155) TERIPARATIDE (146)

Which RITUXIMAB-PVVR Alternatives Have Lower Bone density abnormal Risk?

RITUXIMAB-PVVR vs RIVAROXABAN RITUXIMAB-PVVR vs RIVASTIGMINE RITUXIMAB-PVVR vs RIVOTRIL RITUXIMAB-PVVR vs RIZATRIPTAN RITUXIMAB-PVVR vs ROACTEMRA

Related Pages

RITUXIMAB-PVVR Full Profile All Bone density abnormal Reports All Drugs Causing Bone density abnormal RITUXIMAB-PVVR Demographics